Vimta Labs Share Price
Know More₹602.80-5.95 (-0.98%)
04:01 PM, 5-Dec-2025₹601.55-6.30 (-1.04%)
03:50 PM, 5-Dec-2025BSE : 524394
NSE : VIMTALABS
Sector : Others
ISIN Code : INE579C01029
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 05-Dec-2025 | 04:01 PM IST
| Market Cap (₹ Cr) | 2,692 |
Traded Value (₹ Cr) | 0.31 |
Volume (Shares) | 5,086 |
Face Value (₹) | 2 |
52-Week High (₹) | - |
52-Week High Date | - |
52-Week Low (₹) | - |
52-Week Low Date | - |
All Time High (₹) | - |
All Time High Date | - |
All Time Low (₹) | - |
All Time Low Date | - |
Vimta Labs Ltd
Vimta Labs Ltd News
Vimta Labs Announcement
Vimta Labs Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 2,686 |
| EPS - TTM (₹) [C] | 13.75 |
| P/E Ratio (X) [C] | 43.75 |
| Face Value (₹) | 2 |
| Latest Dividend (%) | 100.00 |
| Latest Dividend Date | 30-May-2025 |
| Dividend Yield (%) | 0.16 |
| Book Value Share (₹) [C] | 76.80 |
| P/B Ratio (₹) [C] | 7.83 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 0.03 | 381 | 0.08 |
| Bandhan BSE Healthcare Index Fund - Regular (G) | 0.01 | 199 | 0.08 |
| Bandhan BSE Healthcare Index Fund - Direct (G) | 0.01 | 199 | 0.08 |
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 593.65 609.90 |
| Week Low/High (₹) | 593.65 620.00 |
| Month Low/High (₹) | 593.65 690.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -1.27% | -77.77% | 0.01% | -0.06% |
| 1 Month | -9.04% | -79.53% | 2.70% | 2.30% |
| 3 Month | -31.18% | -84.56% | 6.20% | 5.84% |
| 6 Month | 26.43% | -71.51% | 5.24% | 5.80% |
| 1 Year | 31.30% | -70.40% | 4.83% | 5.98% |
| 3 Year | 177.11% | -37.76% | 36.41% | 40.03% |
Company Info
Company Information
Executive Chairman : S P Vasireddi
Director (Operation) : V Harriman
Managing Director : Harita Vasireddi
Non Executive & Independent Director : Y Prameela Rani
Company Sec. & Compli. Officer : Sujani Vasireddi
Non Executive & Independent Director : G Purnachandra Rao
Non Executive & Independent Director : Sanjay Dave
Executive Director : Satya Sreenivas Neerukonda
Non Executive & Independent Director : Yadagiri R Pendri
Registered Office: Plot No 141/2 & 142, IDA Phase II Cherlapally,Hyderabad,Telangana-500051 Ph: 91-40-27264141
Email:shares@vimta.com
FAQs about Vimta Labs Ltd
1. What's the Vimta Labs Ltd share price today?
Vimta Labs Ltd share price was Rs 602.80 at 04:01 PM IST on 5th Dec 2025. Vimta Labs Ltd share price was down by 0.98% from the previous closing price of Rs 608.75. Vimta Labs Ltd share price trend:
- Last 1 Month: Vimta Labs Ltd share price moved down by 9.04% on BSE.
- Last 3 Months: Vimta Labs Ltd share price moved down by 31.18% on BSE.
- Last 12 Months: Vimta Labs Ltd share price moved up by 31.30% on BSE.
- Last 3 Years: Vimta Labs Ltd share price moved up by 177.11% on BSE.
2. How can I quickly analyse the performance of the Vimta Labs Ltd stock?
The performance of the Vimta Labs Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 43.75
- Price to book value ratio is 7.83
- Dividend yield of 0.16
- The EPS (trailing 12 months) of the Vimta Labs Ltd stock is Rs 13.75
3. What is the market cap of Vimta Labs Ltd?
Vimta Labs Ltd has a market capitalisation of Rs 2,692 crore.
5. Is the Vimta Labs Ltd profitable?
On a consolidated basis, Vimta Labs Ltd reported a profit of Rs 21.50 crore on a total income of Rs 95.13 crore for the quarter ended 2024.
6. Which are Vimta Labs Ltd’s peers in the Others sector?
Vimta Labs Ltd’s top 5 peers in the Others sector are Indrapr.Medical, Artemis Medicare, Suven Life Scie., Vimta Labs, Dr Agarwal's Eye, Krsnaa Diagnost., Shalby.
7. Who owns how much in Vimta Labs Ltd?
Key changes to the Vimta Labs Ltd shareholding are as follows:
- Promoter holding in Vimta Labs Ltd has gone down to 35.99 per cent as of Sep 2025 from 36.70 per cent as of Mar 2025.
